Related Experiment Video
Updated: Jun 16, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement
P M van der Zee1, E Biró, L A Trouw
1Department of Cardiology, Academic Medical Center of the University of Amsterdam, 1105 AZ Amsterdam, The Netherlands. p.m.vanderzee@amc.uva.nl
Background:
C-reactive protein (CRP) is elevated in patients with acute myocardial infarction (AMI). When CRP binds to membrane phospholipids or Fc receptors, it activates the complement system. Recent studies show that CRP can be exposed on cell-derived microparticles (MP) and is associated complement activation.
Objectives:
We studied complement activation on circulating MP in AMI patients and healthy controls.
Methods:
MP were isolated from plasma of AMI patients (n=21) and sex- and age-matched healthy individuals (n=10), and analyzed by flow cytometry for bound complement components (C1q, C4, C3) and complement inhibitor and activator molecules (C4bp, CRP, serum amyloid P component, immunoglobulins IgM and IgG). Concurrently, the levels of fluid phase complement activation products and inhibitor and activator molecules were determined.
Results:
Fluid phase CRP, MP with bound CRP (CRP + MP), and C3 activation products were elevated in AMI patients compared to controls (P=0.032, P=0.031 and P=0.023, respectively), and fluid phase CRP correlated with CRP+ MP (r=0.84, P<0.001). Although CRP+ MP were elevated, they were not associated with C1q+ MP (r=0.32, P=0.174). In contrast, IgG+ MP were associated with C1q+ MP (r=0.73, P<0.001), C4+ MP and C3+ MP (r=0.78 and r=0.87, respectively; both P<0.001), and C4bp (r=0.63, P=0.004). In healthy individuals, CRP+ MP were strongly associated with C1q+ MP (r=0.82, P=0.007), which in turn were associated with C4+ MP and C3+ MP (r=0.68, P=0.032 and r=0.68, P=0.031, respectively).
Conclusions:
Despite CRP-associated complement activation on the surface of MP in healthy individuals and a strong correlation between MP-bound CRP and fluid phase CRP in AMI patients, the MP-associated complement activation is IgG- but not CRP-dependent in AMI patients.
Insights
In acute myocardial infarction (AMI) patients, complement activation on microparticles (MP) is IgG-dependent, not CRP-dependent, despite elevated C-reactive protein (CRP) levels. This finding differs from healthy individuals where CRP drives complement activation on MP.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Complement System Biology
Background:
- C-reactive protein (CRP) elevation is a hallmark of acute myocardial infarction (AMI).
- CRP binding can activate the complement system, a key part of innate immunity.
- CRP has been observed on cell-derived microparticles (MP), suggesting a role in complement activation.
Purpose of the Study:
- To investigate complement activation on circulating microparticles (MP) in patients with AMI.
- To compare complement activation on MP between AMI patients and healthy controls.
- To determine the role of C-reactive protein (CRP) in MP-associated complement activation in AMI.
Main Methods:
- Isolation of MP from plasma of AMI patients and healthy controls.
- Flow cytometry analysis of MP for bound complement components (C1q, C4, C3) and associated molecules (CRP, IgG).
- Measurement of fluid-phase complement activation products and regulatory molecules.
Main Results:
- AMI patients showed elevated fluid-phase CRP, CRP-bound MP (CRP+MP), and C3 activation products compared to controls.
- Fluid-phase CRP strongly correlated with CRP+MP in AMI patients.
- In AMI patients, MP-associated complement activation was linked to IgG, not CRP, while in healthy individuals, it was CRP-dependent.
Conclusions:
- Complement activation on microparticles in AMI patients is primarily IgG-dependent.
- Despite elevated CRP and its correlation with MP in AMI, CRP does not appear to be the primary driver of complement activation on MP in this condition.
- These findings highlight a differential mechanism of MP-mediated complement activation between AMI and healthy states.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests
